top of page

This site was designed with the

website builder. Create your website today.Start Now

Factbox: Neuralink: what you need to know about Elon Musk's brain chip company

Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that would enable the paralyzed to walk and the blind to see.

Here is more on what Neuralink does.

WHAT IS NEURALINK DEVELOPING?

Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.

Neuralink's device has a chip that processes and transmits neural signals that could be transmitted to devices like a computer or a phone.

The company hopes that a person would potentially be able to control a mouse, keyboard or other computer functions like text messaging with their thoughts.

"First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs," Musk said in April 2021.

Neuralink also believes its device will eventually be able to restore neural activity inside the body, allowing those with spinal cord injuries to move limbs. The San Francisco and Austin-based company also aspires to cure neurological conditions such as Alzheimer's and dementia.

WHAT PROGRESS HAS NEURALINK MADE?

Neuralink has produced several examples of testing aspects of its technology successfully on animals, including a video in 2021 that showed a macaque playing a simple videogame after being implanted with a brain chip. In a presentation webcast last week, the company showcased improvements in the speed and capabilities of the chip.

WHAT HURDLES FOR NEURALINK NEXT?

Neuralink has yet to secure U.S. regulatory approval to move to human trials - unlike competitor Synchron, which has less ambitious goals for its medical advances. Neuralink has missed Musk's publicly stated deadlines to start human trials and this year submitted its application to the Food and Drug Administration to begin them. Musk said last week he believes Neuralink can start human clinical trials in six months.

CONTROVERSY AROUND ANIMAL TESTING

The company is facing a federal probe for potential animal-welfare violations at a time when its staff has complained that the testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations.

In all, the company has killed about 1,500 animals, including more than 280 sheep, pigs and monkeys, following experiments since 2018.

Source: Reuters

Factbox: Neuralink: what you need to know about Elon Musk's brain chip company

Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that would enable the paralyzed to walk and the blind to see.

Here is more on what Neuralink does.

WHAT IS NEURALINK DEVELOPING?

Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.

Neuralink's device has a chip that processes and transmits neural signals that could be transmitted to devices like a computer or a phone.

The company hopes that a person would potentially be able to control a mouse, keyboard or other computer functions like text messaging with their thoughts.

"First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs," Musk said in April 2021.

Neuralink also believes its device will eventually be able to restore neural activity inside the body, allowing those with spinal cord injuries to move limbs. The San Francisco and Austin-based company also aspires to cure neurological conditions such as Alzheimer's and dementia.

WHAT PROGRESS HAS NEURALINK MADE?

Neuralink has produced several examples of testing aspects of its technology successfully on animals, including a video in 2021 that showed a macaque playing a simple videogame after being implanted with a brain chip. In a presentation webcast last week, the company showcased improvements in the speed and capabilities of the chip.

WHAT HURDLES FOR NEURALINK NEXT?

Neuralink has yet to secure U.S. regulatory approval to move to human trials - unlike competitor Synchron, which has less ambitious goals for its medical advances. Neuralink has missed Musk's publicly stated deadlines to start human trials and this year submitted its application to the Food and Drug Administration to begin them. Musk said last week he believes Neuralink can start human clinical trials in six months.

CONTROVERSY AROUND ANIMAL TESTING

The company is facing a federal probe for potential animal-welfare violations at a time when its staff has complained that the testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations.

In all, the company has killed about 1,500 animals, including more than 280 sheep, pigs and monkeys, following experiments since 2018.

Source: Reuters

Factbox: Neuralink: what you need to know about Elon Musk's brain chip company

Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that would enable the paralyzed to walk and the blind to see.

Here is more on what Neuralink does.

WHAT IS NEURALINK DEVELOPING?

Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.

Neuralink's device has a chip that processes and transmits neural signals that could be transmitted to devices like a computer or a phone.

The company hopes that a person would potentially be able to control a mouse, keyboard or other computer functions like text messaging with their thoughts.

"First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs," Musk said in April 2021.

Neuralink also believes its device will eventually be able to restore neural activity inside the body, allowing those with spinal cord injuries to move limbs. The San Francisco and Austin-based company also aspires to cure neurological conditions such as Alzheimer's and dementia.

WHAT PROGRESS HAS NEURALINK MADE?

Neuralink has produced several examples of testing aspects of its technology successfully on animals, including a video in 2021 that showed a macaque playing a simple videogame after being implanted with a brain chip. In a presentation webcast last week, the company showcased improvements in the speed and capabilities of the chip.

WHAT HURDLES FOR NEURALINK NEXT?

Neuralink has yet to secure U.S. regulatory approval to move to human trials - unlike competitor Synchron, which has less ambitious goals for its medical advances. Neuralink has missed Musk's publicly stated deadlines to start human trials and this year submitted its application to the Food and Drug Administration to begin them. Musk said last week he believes Neuralink can start human clinical trials in six months.

CONTROVERSY AROUND ANIMAL TESTING

The company is facing a federal probe for potential animal-welfare violations at a time when its staff has complained that the testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations.

In all, the company has killed about 1,500 animals, including more than 280 sheep, pigs and monkeys, following experiments since 2018.

Source: Reuters

™

SHIFT, The Lord's Healing - Book

Garden & Cook

Never Miss Updates, Sign Up for Mailing List

Search

Malady mongers: How drug companies sell treatments by inventing diseases, Series P4

Shidonna Raven
2 hours ago
1 min read

By Michael Walsh

June 8, 2018

Source: Yahoo News

Photo / Image Source: Unsplash,

The United States was still the largest single pharmaceutical market in 2017, generating more than $450 billion of revenue. In contrast, all of Europe accounted for roughly $214 billion. U.S. pharmaceutical spending alone is double the Organisation for Economic Co-operation and Development average. According to the Mayo Clinic, nearly 70 percent of Americans take at least one prescription drug.

COVID Vaccine. Shidonna Raven Garden & Cook, Soaring by Design

Fitness & Exercise

Share the wealth of health with your friends and family by sharing this article with 3 people today.

If this article was helpful to you, donate to the Shidonna Raven Garden and Cook E-Magazine Today. Thank you in advance.

Recent Posts

Pharmaceutical. Chidonna Raven Garden & Cook

Malady mongers: How drug companies sell treatments by inventing diseases, Series P3

Pharmaceutical. Chidonna Raven Garden & Cook

Malady mongers: How drug companies sell treatments by inventing diseases, Series P2

Pharmaceutical. Chidonna Raven Garden & Cook

Malady mongers: How drug companies sell treatments by inventing diseases, Series P1

bottom of page